X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
biodefense (36) 36
animals (30) 30
humans (26) 26
index medicus (23) 23
immunology (20) 20
mice (15) 15
vaccines (13) 13
toxin (10) 10
article (9) 9
biological weapons (9) 9
bioterrorism (9) 9
medicine, research & experimental (9) 9
proteins (9) 9
biodefence (7) 7
female (7) 7
monoclonal antibodies (7) 7
pharmacology & pharmacy (7) 7
vaccine (7) 7
allergy and immunology (6) 6
amino acid sequence (6) 6
antibody (6) 6
health aspects (6) 6
mice, inbred balb c (6) 6
molecular sequence data (6) 6
a-chain (5) 5
biological warfare (5) 5
biotechnology & applied microbiology (5) 5
identification (5) 5
lectins (5) 5
neutralization tests (5) 5
ricin - immunology (5) 5
antibodies, neutralizing - immunology (4) 4
antiviral agents (4) 4
bacillus-anthracis (4) 4
biological warfare agents (4) 4
immunity (4) 4
immunoglobulins (4) 4
infection (4) 4
neutralizing (4) 4
poisoning - prevention & control (4) 4
protection (4) 4
ricin - toxicity (4) 4
toxins (4) 4
virology (4) 4
viruses (4) 4
analysis (3) 3
anthrax (3) 3
antigenic determinants (3) 3
antigens (3) 3
binding (3) 3
biochemistry & molecular biology (3) 3
bioterrorism - prevention & control (3) 3
cytotoxicity (3) 3
epidemiology (3) 3
epitopes (3) 3
equine encephalitis-virus (3) 3
expressed sequence tags (3) 3
immune-responses (3) 3
infectious diseases (3) 3
leukocytes (3) 3
monoclonal-antibodies (3) 3
mycobacterium-tuberculosis (3) 3
peptides (3) 3
prevention (3) 3
proteomics (3) 3
ricin - antagonists & inhibitors (3) 3
smallpox (3) 3
therapeutic (3) 3
vaccination - methods (3) 3
vaccines - immunology (3) 3
vaccines, subunit - immunology (3) 3
veterinary sciences (3) 3
virus diseases (3) 3
aerosols (2) 2
amino acids (2) 2
animal diseases (2) 2
anthrax toxin (2) 2
antibodies (2) 2
antibodies, monoclonal - immunology (2) 2
antibodies, neutralizing - therapeutic use (2) 2
antibodies, viral - immunology (2) 2
antibody specificity (2) 2
antigens, bacterial - genetics (2) 2
antigens, bacterial - immunology (2) 2
apoptosis (2) 2
bacterial toxins - immunology (2) 2
bacterial toxins - toxicity (2) 2
bacterial vaccines - immunology (2) 2
base sequence (2) 2
biochemical research methods (2) 2
biological response modifiers (2) 2
biomarkers (2) 2
biosensor (2) 2
cdna library (2) 2
cell culture (2) 2
cell line (2) 2
cercopithecus aethiops (2) 2
challenge (2) 2
communicable diseases, emerging - epidemiology (2) 2
competition (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Antiviral Research, ISSN 0166-3542, 2008, Volume 78, Issue 1, pp. 51 - 59
Severe viral infections, including hemorrhagic fever and encephalitis, occur throughout the world, but are most prevalent in developing areas that are most... 
Junin | Human herpes virus 8 | Medicinal chemistry | Phase I clinical trials | Pichinde | Pharmacodynamic | Antiviral testing program | Recombinant proteins | Cloned genes | Papillomaviruses | Formulation | Epstein-Barr virus | Synthesis/resynthesis | Synthetic peptides | Hepatitis B virus | Immunomodulatory | Chemical synthesis | Human herpes virus 6 | Yellow fever | Rift valley fever | Influenza type A | BK virus | Nucleic acids | Cationic lipid–DNA complexes (CLDC) | Pharmacokinetic | Biodefense and emerging infections repository | BEIR | Intellectual property option (IP option) | BLA | Monoclonal antibodies | Anti-inflammatory | IND | Determination of exceptional circumstances (DEC) | Juvaris BioTherapeutics | Highly pathogenic RNA viruses | West nile | NDA | Avian H5N1 | Patent protection | Severe acute respiratory syndrome (SARS)-associated coronavirus | Herpes simplex type 1 and type 2 | Rhinoviruses | Measles | Venezuelan equine encephalitis | Manufacturing | Orthopoxviruses | Clinical evaluations | Parainfluenza | NIAID Category A, B and C | Cytomegalovirus | Screening agreement | Dengue | Varicella-Zoster virus | Radiolabeled compounds | NIAID | Hamster-scrapie | Western equine encephalitis viruses | Vaccinia virus | In vivo testing submission form | Services for the preclinical development of therapeutic agents | Lassa fever | Respiratory syncytial virus | HIV | Adenoviruses | Filoviruses | Intellectual property | Hepatitis C virus | Cowpox virus | Tacaribe | BSL-4 containment | Cationic lipid-DNA complexes (CLDC) | cowpox virus | hepatitis B virus | lassa fever | N-METHANOCARBATHYMIDINE | venezuelan equine encephalitis | screening agreement | parainfluenza | cytomegalovirus | orthopoxviruses | western equine encephalitis viruses | formulation | manufacturing | PHARMACOLOGY & PHARMACY | synthesis/resynthesis | avian H5N1 | human herpes virus 6 | highly pathogenic RNA viruses | NIAID category A | antiviral testing program | nucleic acids | filoviruses | phase I clinical trials | ETHER LIPID ESTERS | varicella-zoster virus | intellectual property | juvaris BioTherapeutics | in vivo testing submission form | synthetic peptides | pharmacodynamic | respiratory syncytial virus | west nile | human herpes virus 8 | immunomodulatory | influenza type A | services for the preclinical development of therapeutic agents | rift valley fever | yellow fever | HAMSTER MODEL | COTTON RATS | vaccinia virus | papillomaviruses | VIROLOGY | determination of exceptional circumstances (DEC) | intellectual property option (IP option) | anti-inflammatory | hepatitis C virus | adenoviruses | B and C | pharmacokinetic | IN-VIVO ACTIVITIES | medicinal chemistry | LETHAL MOUSEPOX MODEL | severe acute respiratory syndrome (SARS)-associated | WEST-NILE-VIRUS | recombinant proteins | herpes simplex type 1 and type 2 | patent protection | coronavirus | CYTOMEGALOVIRUS-INFECTION | dengue | cloned genes | ORTHOPOXVIRUS INFECTIONS | chemical synthesis | cationic lipid-DNA complexes (CLDC) | clinical evaluations | biodefense and emerging infections repository | measles | radiolabeled compounds | hamster-scrapie | monoclonal antibodies | Private Sector | Severity of Illness Index | Cricetinae | Antiviral Agents - therapeutic use | United States | Humans | Research Support as Topic | Biotechnology - methods | Program Development | Animals | Virus Diseases - drug therapy | Virus Diseases - physiopathology | Dogs | Mice | National Institute of Allergy and Infectious Diseases (U.S.) | Drug Evaluation, Preclinical | Antiviral agents | Peptides | RNA | Avian influenza viruses | Development and progression | Hamsters | Case studies | Avian influenza | Rift Valley fever | Ebola virus infections | Product development | Hepatitis C | Health aspects
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2006, Volume 103, Issue 6, pp. 1882 - 1887
Journal Article
Molecular Aspects of Medicine, ISSN 0098-2997, 2008, Volume 29, Issue 3, pp. 151 - 185
Journal Article
Vaccine, ISSN 0264-410X, 2011, Volume 30, Issue 7, pp. 1239 - 1243
Journal Article